Top

Published in:

01-09-2012 | Original Article

Early lesions in lymphoid neoplasia

Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology in Uppsala, Sweden

Authors: Falko Fend, José Cabecadas, Philippe Gaulard, Elaine S. Jaffe, Philip Kluin, Isinsu Kuzu, LoAnn Peterson, Andrew Wotherspoon, Christer Sundström

Published in: Journal of Hematopathology | Issue 3/2012

Abstract

The increasing use of immunophenotypic and molecular techniques on lymphoid tissue samples without obvious involvement of malignant lymphoma has resulted in the increased detection of ‘early’ lymphoid proliferations which show some, but not all, of the criteria necessary for a diagnosis of malignant lymphoma. In most instances, these are incidental findings in asymptomatic individuals, and their biological behaviour is uncertain. In order to better characterize these premalignant conditions and to establish diagnostic criteria, a joint workshop of the European Association for Haematopathology and the Society of Hematopathology was held in Uppsala, Sweden, in September 2010. The panel reviewed and discussed more than 130 submitted cases and reached consensus diagnoses. Cases representing the nodal equivalent of monoclonal B cell lymphocytosis were discussed, as well as the ‘in situ’ counterparts of follicular lymphoma (FL) and mantle cell lymphoma, topics that also stimulated discussions concerning the best terminology for these lesions. The workshop also addressed the borderland between reactive hyperplasia and clonal proliferations such as paediatric marginal zone lymphoma and paediatric FL, which may have very limited capacity for progression. Virus-driven lymphoproliferations in the grey zone between reactive lesions and manifest malignant lymphoma were covered. Finally, early manifestations of T cell lymphoma, both nodal and extranodal, and their mimics were addressed. This workshop report summarizes the most important conclusions concerning the diagnostic features, as well as proposals for terminology and classification, of early lymphoproliferations and tries to give some practical guidelines for diagnosis and reporting.

Campo E, Chott A, Kinney MC, Leoncini L, Meijer CJ, Papadimitriou CS et al (2006) Update on extranodal lymphomas. Conclusions of the workshop held by the EAHP and the SH in Thessaloniki, Greece. Histopathology 48:481–504PubMedCrossRef

Quintanilla-Martinez L, de Jong D, de Mascarel A, Hsi ED, Kluin P, Natkunam Y et al (2009) Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV Meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. J Hematop 2:211–236PubMedCrossRef

Lennert K, Muller-Hermelink HK (1975) Lymphocytes and their functional forms—morphology, organization and immunologic significance. Verh Anat Ges 69:19–62PubMed

Osborne BM, Butler JJ, Gresik MV (1992) Progressive transformation of germinal centers: comparison of 23 pediatric patients to the adult population. Mod Pathol 5:135–140PubMed

Ferry JA, Zukerberg LR, Harris NL (1992) Florid progressive transformation of germinal centers. A syndrome affecting young men, without early progression to nodular lymphocyte predominance Hodgkin’s disease. Am J Surg Pathol 16:252–258PubMedCrossRef

Poppema S, Kaiserling E, Lennert K (1979) Hodgkin’s disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres—a cytohistological study. Histopathology 3:295–308PubMedCrossRef

Poppema S, Kaiserling E, Lennert K (1979) Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol 31:211–225PubMedCrossRef

Brauninger A, Yang W, Wacker HH, Rajewsky K, Kuppers R, Hansmann ML (2001) B-cell development in progressively transformed germinal centers: similarities and differences compared with classical germinal centers and lymphocyte-predominant Hodgkin disease. Blood 97:714–719PubMedCrossRef

Hansmann ML, Fellbaum C, Hui PK, Moubayed P (1990) Progressive transformation of germinal centers with and without association to Hodgkin’s disease. Am J Clin Pathol 93:219–226PubMed

10.

Rahemtullah A, Reichard KK, Preffer FI, Harris NL, Hasserjian RP (2006) A double-positive CD4⁺CD8⁺ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. Am J Clin Pathol 126:805–814PubMedCrossRef

11.

Chang CC, Osipov V, Wheaton S, Tripp S, Perkins SL (2003) Follicular hyperplasia, follicular lysis, and progressive transformation of germinal centers. A sequential spectrum of morphologic evolution in lymphoid hyperplasia. Am J Clin Pathol 120:322–326PubMedCrossRef

12.

Nguyen PL, Ferry JA, Harris NL (1999) Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin’s disease: a comparative immunohistochemical study. Am J Surg Pathol 23:27–33PubMedCrossRef

13.

Taddesse-Heath L, Pittaluga S, Sorbara L, Bussey M, Raffeld M, Jaffe ES (2003) Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol 27:522–531PubMedCrossRef

14.

Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Dominguez-Franjo P et al (2008) PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 32:1252–1257PubMedCrossRef

15.

Kussick SJ, Kalnoski M, Braziel RM, Wood BL (2004) Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. Am J Clin Pathol 121:464–472PubMedCrossRef

16.

Finn LS, Viswanatha DS, Belasco JB, Snyder H, Huebner D, Sorbara L et al (1999) Primary follicular lymphoma of the testis in childhood. Cancer 85:1626–1635PubMedCrossRef

17.

Lorsbach RB, Shay-Seymore D, Moore J, Banks PM, Hasserjian RP, Sandlund JT et al (2002) Clinicopathologic analysis of follicular lymphoma occurring in children. Blood 99:1959–1964PubMedCrossRef

18.

Oschlies I, Salaverria I, Mahn F, Meinhardt A, Zimmermann M, Woessmann W et al (2010) Pediatric follicular lymphoma—a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin’s Lymphoma–Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials. Haematologica 95:253–259PubMedCrossRef

19.

Swerdlow SH (2004) Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia. Am J Clin Pathol 122(Suppl):S98–S109PubMed

20.

Sheibani K, Sohn CC, Burke JS, Winberg CD, Wu AM, Rappaport H (1986) Monocytoid B-cell lymphoma. A novel B-cell neoplasm. Am J Pathol 124:310–318PubMed

21.

Salama ME, Lossos IS, Warnke RA, Natkunam Y (2009) Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases. Am J Clin Pathol 132:39–49PubMedCrossRef

22.

Elenitoba-Johnson KS, Kumar S, Lim MS, Kingma DW, Raffeld M, Jaffe ES (1997) Marginal zone B-cell lymphoma with monocytoid B-cell lymphocytes in pediatric patients without immunodeficiency. A report of two cases. Am J Clin Pathol 107:92–98PubMed

23.

Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M et al (2010) Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol 23:866–873PubMedCrossRef

24.

Gitelson E, Al-Saleem T, Robu V, Millenson MM, Smith MR (2010) Pediatric nodal marginal zone lymphoma may develop in the adult population. Leuk Lymphoma 51:89–94PubMedCrossRef

25.

Attygalle AD, Liu H, Shirali S, Diss TC, Loddenkemper C, Stein H et al (2004) Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood 104:3343–3348PubMedCrossRef

26.

Kojima M, Nakamura S, Itoh H, Yoshida K, Shimizu K, Motoori T et al (1998) Occurrence of monocytoid B-cells in reactive lymph node lesions. Pathol Res Pract 194:559–565PubMedCrossRef

27.

Hunt JP, Chan JA, Samoszuk M, Brynes RK, Hernandez AM, Bass R et al (2001) Hyperplasia of mantle/marginal zone B cells with clear cytoplasm in peripheral lymph nodes. A clinicopathologic study of 35 cases. Am J Clin Pathol 116:550–559PubMedCrossRef

28.

Kojima M, Nakamura S, Tanaka H, Yamane Y, Sugihara S, Masawa N (2003) Massive hyperplasia of marginal zone B-cells with clear cytoplasm in the lymph node: a case report. Pathol Res Pract 199:625–628PubMedCrossRef

29.

Kojima M, Motoori T, Iijima M, Ono T, Yoshizumi T, Matsumoto M et al (2006) Florid monocytoid B-cell hyperplasia resembling nodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue type. A histological and immunohistochemical study of four cases. Pathol Res Pract 202:877–882

30.

Kojima M, Nakamura S, Motoori T, Shimizu K, Ohno Y, Itoh H et al (2002) Follicular hyperplasia presenting with a marginal zone pattern in a reactive lymph node lesion. APMIS 110:325–331PubMedCrossRef

31.

Viswanatha DS, Dogan A (2007) Hepatitis C virus and lymphoma. J Clin Pathol 60:1378–1383PubMedCrossRef

32.

Charles ED, Green RM, Marukian S, Talal AH, Lake-Bakaar GV, Jacobson IM et al (2008) Clonal expansion of immunoglobulin M⁺CD27⁺ B cells in HCV-associated mixed cryoglobulinemia. Blood 111:1344–1356PubMedCrossRef

33.

Curry MP, Golden-Mason L, Doherty DG, Deignan T, Norris S, Duffy M et al (2003) Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol 38:642–650PubMedCrossRef

34.

Zuckerman E, Slobodin G, Kessel A, Sabo E, Yeshurun D, Halas K et al (2002) Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol 128:353–358PubMedCrossRef

35.

Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES (1992) Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 16:1170–1182PubMedCrossRef

36.

Au WY, Horsman DE, Connors JM, Klasa RJ, Gascoyne RD (2002) Cytogenetic findings in reactive lymphoid hyperplasia: significance of non-clonal t(3;14) and t(3;22). Am J Hematol 70:133–138PubMedCrossRef

37.

Gordon DS, Jones BM, Browning SW, Spira TJ, Lawrence DN (1982) Persistent polyclonal lymphocytosis of B lymphocytes. N Engl J Med 307:232–236PubMedCrossRef

38.

Troussard X, Flandrin G (1996) Chronic B-cell lymphocytosis with binucleated lymphocytes (LWBL): a review of 38 cases. Leuk Lymphoma 20:275–279PubMedCrossRef

39.

Casassus P, Lortholary P, Komarover H, Lejeune F, Hors J (1987) Cigarette smoking-related persistent polyclonal B lymphocytosis. A premalignant state. Arch Pathol Lab Med 111:1081PubMed

40.

Delage R, Jacques L, Massinga-Loembe M, Poulin J, Bilodeau D, Mignault C et al (2001) Persistent polyclonal B-cell lymphocytosis: further evidence for a genetic disorder associated with B-cell abnormalities. Br J Haematol 114:666–670PubMedCrossRef

41.

Machii T, Yamaguchi M, Inoue R, Tokumine Y, Kuratsune H, Nagai H et al (1997) Polyclonal B-cell lymphocytosis with features resembling hairy cell leukemia-Japanese variant. Blood 89:2008–2014PubMed

42.

Himmelmann A, Gautschi O, Nawrath M, Bolliger U, Fehr J, Stahel RA (2001) Persistent polyclonal B-cell lymphocytosis is an expansion of functional IgD(+)CD27(+) memory B cells. Br J Haematol 114:400–405PubMedCrossRef

43.

Loembe MM, Lamoureux J, Deslauriers N, Darveau A, Delage R (2001) Lack of CD40-dependent B-cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B-cell lymphocytosis. Br J Haematol 113:699–705PubMedCrossRef

44.

Larcher C, Fend F, Mitterer M, Prang N, Schwarzmann F, Huemer HP (1995) Role of Epstein–Barr virus and soluble CD21 in persistent polyclonal B-cell lymphocytosis. Br J Haematol 90:532–540PubMedCrossRef

45.

Mossafa H, Troussard X, Valensi F, Schillinger F, Maynadie M, Bulliard G et al (1996) Isochromosome i(3q) and premature chromosome condensation are recurrent findings in chronic B-cell lymphocytosis with binucleated lymphocytes. Leuk Lymphoma 20:267–273PubMedCrossRef

46.

Callet-Bauchu E, Gazzo S, Poncet C, Pages J, Morel D, Alliot C et al (1999) Distinct chromosome 3 abnormalities in persistent polyclonal B-cell lymphocytosis. Gene Chromosome Canc 26:221–228CrossRef

47.

Delage R, Roy J, Jacques L, Darveau A (1998) All patients with persistent polyclonal B cell lymphocytosis present Bcl-2/Ig gene rearrangements. Leuk Lymphoma 31:567–574PubMed

48.

Cornet E, Lesesve JF, Mossafa H, Sebahoun G, Levy V, Davi F et al (2009) Long-term follow-up of 111 patients with persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes. Leukemia 23:419–422PubMedCrossRef

49.

Del Giudice I, Pileri SA, Rossi M, Sabattini E, Campidelli C, Starza ID et al (2009) Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly. Br J Haematol 144:726–731PubMedCrossRef

50.

Feugier P, De March AK, Lesesve JF, Monhoven N, Dorvaux V, Braun F et al (2004) Intravascular bone marrow accumulation in persistent polyclonal lymphocytosis: a misleading feature for B-cell neoplasm. Mod Pathol 17:1087–1096PubMedCrossRef

51.

Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC (2010) Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 24:512–520PubMedCrossRef

52.

Dagklis A, Fazi C, Sala C, Cantarelli V, Scielzo C, Massacane R et al (2009) The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Blood 114:26–32PubMedCrossRef

53.

Lanasa MC, Allgood SD, Volkheimer AD, Gockerman JP, Whitesides JF, Goodman BK et al (2010) Single-cell analysis reveals oligoclonality among ‘low-count’ monoclonal B-cell lymphocytosis. Leukemia 24:133–140PubMedCrossRef

54.

Rawstron AC, Hillmen P (2011) Clinical and diagnostic implications of monoclonal B-cell lymphocytosis. Best Pract Res Clin Haematol 23:61–69CrossRef

55.

Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, Marti GE, Caporaso NE (2009) B-cell clones as early markers for chronic lymphocytic leukemia. New Engl J Med 360:659–667PubMedCrossRef

56.

Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A et al (2010) Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 78(Suppl 1):S19–S23PubMed

57.

Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E et al (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101:4975–4981PubMedCrossRef

58.

Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A et al (2010) Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 70:1408–1418PubMedCrossRef

59.

Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B et al (2008) The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol 143:248–252PubMedCrossRef

60.

Waldenstrom J (1952) Three new cases of purpura hyperglobulinemica. A study in long-lasting benign increase in serum globulin. Acta Med Scand Suppl 266:931–946PubMed

61.

Kyle RA (1978) Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med 64:814–826PubMedCrossRef

62.

Kyle RA, Rajkumar SV (2007) Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Br J Haematol 139:730–743PubMedCrossRef

63.

Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM (2009) A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 113:5418–5422PubMedCrossRef

64.

Shao H, Xi L, Raffeld M, Pittaluga S, Dunleavy K, Wilson WH et al (2010) Nodal and extranodal plasmacytomas expressing immunoglobulin A: an indolent lymphoproliferative disorder with a low risk of clinical progression. Am J Surg Pathol 34:1425–1435PubMedCrossRef

65.

Weyers W, Ende Y, Schalla W, Diaz-Cascajo C (2002) Balanitis of Zoon: a clinicopathologic study of 45 cases. Am J Dermatopathol 24:459–467PubMedCrossRef

66.

Cong P, Raffeld M, Teruya-Feldstein J, Sorbara L, Pittaluga S, Jaffe ES (2002) In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 99:3376–3382

67.

Limpens J, de Jong D, van Krieken JH, Price CG, Young BD, van Ommen GJ et al (1991) Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271–2276PubMed

68.

Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ et al (1995) Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85:2528–2536PubMed

69.

Roulland S, Lebailly P, Lecluse Y, Heutte N, Nadel B, Gauduchon P (2006) Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals. Leukemia 20:158–162PubMedCrossRef

70.

Roulland S, Lebailly P, Lecluse Y, Briand M, Pottier D, Gauduchon P (2004) Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides. Cancer Res 64:2264–2269PubMedCrossRef

71.

Cheung MC, Bailey D, Pennell N, Imrie KR, Berinstein NL, Amato D et al (2009) In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node. Leukemia 23:1176–1179PubMedCrossRef

72.

Henopp T, Quintanilla-Martinez L, Fend F, Adam P (2011) Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes. Histopathology 59:139–142PubMedCrossRef

73.

Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S et al (2011) Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood 118:2976–2984PubMedCrossRef

74.

Schmatz AI, Streubel B, Kretschmer-Chott E, Puspok A, Jager U, Mannhalter C et al (2011) Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol 29:1445–1451PubMedCrossRef

75.

Adam P, Katzenberger T, Eifert M, Ott MM, Rosenwald A, Muller-Hermelink HK et al (2005) Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage. Am J Surg Pathol 29:1661–1664PubMedCrossRef

76.

Campo E, Raffeld M, Jaffe ES (1999) Mantle cell lymphoma. Semin Hematol 36:115–127PubMed

77.

Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY et al (2012) In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica 97:270–278PubMedCrossRef

78.

Espinet B, Sole F, Pedro C, Garcia M, Bellosillo B, Salido M et al (2005) Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma? Hum Pathol 36:1232–1237PubMedCrossRef

79.

Nodit L, Bahler DW, Jacobs SA, Locker J, Swerdlow SH (2003) Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol 34:1030–1034PubMedCrossRef

80.

Richard P, Vassallo J, Valmary S, Missoury R, Delsol G, Brousset P (2006) “In situ-like” mantle cell lymphoma: a report of two cases. J Clin Pathol 59:995–996PubMedCrossRef

81.

Aqel N, Barker F, Patel K, Naresh KN (2008) In-situ mantle cell lymphoma—a report of two cases. Histopathology 52:256–260PubMedCrossRef

82.

Gao J, Peterson L, Nelson B, Goolsby C, Chen YH (2009) Immunophenotypic variations in mantle cell lymphoma. Am J Clin Pathol 132:699–706PubMedCrossRef

83.

Hirt C, Schuler F, Dolken L, Schmidt CA, Dolken G (2004) Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood 104:904–905PubMedCrossRef

84.

Lecluse Y, Lebailly P, Roulland S, Gac AC, Nadel B, Gauduchon P (2009) t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia 23:1190–1193PubMedCrossRef

85.

Chen YH, Gao J, Fan G, Peterson LC (2010) Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms. Mod Pathol 23:105–112PubMedCrossRef

86.

Dictor M, Ek S, Sundberg M, Warenholt J, Gyorgy C, Sernbo S et al (2009) Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt’s lymphoma. Haematologica 94:1563–1568PubMedCrossRef

87.

Mozos A, Royo C, Hartmann E, De Jong D, Baro C, Valera A et al (2009) SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 94:1555–1562PubMedCrossRef

88.

Fend F, Quintanilla-Martinez L, Kumar S, Beaty MW, Blum L, Sorbara L et al (1999) Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection. Am J Pathol 154:1857–1866PubMedCrossRef

89.

Roullet MR, Martinez D, Ma L, Fowler MH, McPhail ED, Judkins A et al (2010) Coexisting follicular and mantle cell lymphoma with each having an in situ component: a novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma. Am J Clin Pathol 133:584–591PubMedCrossRef

90.

Kim B, Roth C, Chung KC, Young VL, van Busum K, Schnyer C et al (2011) Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg 127:2141–2150PubMedCrossRef

91.

Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A (2008) Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 21:455–463PubMedCrossRef

92.

Takeuchi K, Yokoyama M, Ishizawa S, Terui Y, Nomura K, Marutsuka K et al (2010) Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood 116:5631–5637PubMedCrossRef

93.

Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011) NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood 117:1447–1452PubMedCrossRef

94.

de Leval L, Gisselbrecht C, Gaulard P (2010) Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 148:673–689PubMedCrossRef

95.

Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124–4130PubMedCrossRef

96.

Attygalle A, Al-Jehani R, Diss TC, Munson P, Liu H, Du MQ et al (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 99:627–633PubMedCrossRef

97.

Rodriguez-Justo M, Attygalle AD, Munson P, Roncador G, Marafioti T, Piris MA (2009) Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers. Mod Pathol 22:753–761PubMed

98.

Ree HJ, Kadin ME, Kikuchi M, Ko YH, Go JH, Suzumiya J et al (1998) Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol 22:643–55

99.

Lachenal F, Berger F, Ghesquieres H, Biron P, Hot A, Callet-Bauchu E et al (2007) Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients. Med (Baltimore) 86:282–292CrossRef

100.

Tan BT, Warnke RA, Arber DA (2006) The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn 8:466–475PubMedCrossRef

101.

Vrsalovic MM, Korac P, Dominis M, Ostojic S, Mannhalter C, Kusec R (2004) T- and B-cell clonality and frequency of human herpes viruses-6, -8 and Epstein Barr virus in angioimmunoblastic T-cell lymphoma. Hematol Oncol 22:169–177PubMedCrossRef

102.

Mourad N, Mounier N, Briere J, Raffoux E, Delmer A, Feller A et al (2008) Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d’Etude des Lymphomes de l’Adulte (GELA) trials. Blood 111:4463–4470PubMedCrossRef

103.

Zettl A, Lee SS, Rudiger T, Starostik P, Marino M, Kirchner T et al (2002) Epstein–Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 117:368–379PubMedCrossRef

104.

Willenbrock K, Brauninger A, Hansmann ML (2007) Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein–Barr virus-infected cells in early cases. Br J Haematol 138:733–739PubMedCrossRef

105.

Attygalle AD, Kyriakou C, Dupuis J, Grogg KL, Diss TC, Wotherspoon AC et al (2007) Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 31:1077–1088PubMedCrossRef

106.

Huang Y, Moreau A, Dupuis J, Streubel B, Petit B, Le Gouill S et al (2009) Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 33:682–690PubMedCrossRef

107.

Bacon CM, Paterson JC, Liu H, Payne K, Munson P, Du MQ et al (2008) Peripheral T-cell lymphoma with a follicular growth pattern: derivation from follicular helper T cells and relationship to angioimmunoblastic T-cell lymphoma. Br J Haematol 143:439–441PubMedCrossRef

108.

de Leval L, Savilo E, Longtine J, Ferry JA, Harris NL (2001) Peripheral T-cell lymphoma with follicular involvement and a CD4⁺/bcl-6⁺ phenotype. Am J Surg Pathol 25:395–400

109.

Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A (2006) Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 20:313–318PubMedCrossRef

110.

Wohrer S, Chott A, Drach J, Puspok A, Hejna M, Hoffmann M et al (2004) Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. Ann Oncol 15:1680–1683PubMedCrossRef

111.

Ferreri AJ, Zinzani PL, Govi S, Pileri SA (2011) Enteropathy-associated T-cell lymphoma. Crit Rev Oncol Hematol 79:84–90PubMedCrossRef

112.

Al-Toma A, Goerres MS, Meijer JW, Pena AS, Crusius JB, Mulder CJ (2006) Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 4:315–319PubMedCrossRef

113.

van de Water JM, Cillessen SA, Visser OJ, Verbeek WH, Meijer CJ, Mulder CJ (2010) Enteropathy associated T-cell lymphoma and its precursor lesions. Best Pract Res Clin Gastroenterol 24:43–56CrossRef

114.

Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PG (1997) Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 151:493–498PubMed

115.

Cellier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri B et al (2000) Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 356:203–208PubMedCrossRef

116.

Verbeek WH, Goerres MS, von Blomberg BM, Oudejans JJ, Scholten PE, Hadithi M et al (2008) Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease. Clin Immunol 126:48–56PubMedCrossRef

117.

Malamut G, El Machhour R, Montcuquet N, Martin-Lanneree S, Dusanter-Fourt I, Verkarre V et al (2010) IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest 120:2131–2143PubMedCrossRef

118.

Mention JJ, Ben Ahmed M, Begue B, Barbe U, Verkarre V, Asnafi V et al (2003) Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125:730–745PubMedCrossRef

119.

Chott A, Haedicke W, Mosberger I, Fodinger M, Winkler K, Mannhalter C et al (1998) Most CD56⁺ intestinal lymphomas are CD8⁺CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 153:1483–1490PubMedCrossRef

120.

Deleeuw RJ, Zettl A, Klinker E, Haralambieva E, Trottier M, Chari R et al (2007) Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132:1902–1911PubMedCrossRef

121.

Vega F, Chang CC, Schwartz MR, Preti HA, Younes M, Ewton A et al (2006) Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease. Am J Surg Pathol 30:539–544PubMedCrossRef

122.

Kim B, Roth C, Young VL, Chung KC, van Busum K, Schnyer C et al (2011) Anaplastic large cell lymphoma and breast ımplants: results from a structured expert consultation process. Plast Reconstr Surg 128:629–639PubMedCrossRef

123.

Alobeid B, Sevilla DW, El-Tamer MB, Murty VV, Savage DG, Bhagat G (2009) Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma 50:831–833PubMedCrossRef

124.

Straus SE (1992) Acute progressive Epstein–Barr virus infections. Annu Rev Med 43:437–449PubMedCrossRef

125.

Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS et al (2008) Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 58:209–217PubMedCrossRef

126.

Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES (2009) Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008. Ann Oncol 20:1472–1482PubMedCrossRef

127.

Quintanilla-Martinez L, Kimura H, Jaffe ES (2008) EBV-positive T-cell lymphoproliferative disorders of childhood. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon

128.

Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM et al (2011) Characterization and treatment of chronic active Epstein–Barr virus disease: a 28-year experience in the United States. Blood 117:5835–5849PubMedCrossRef

129.

Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D et al (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95:1406–1412PubMed

130.

Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabecadas J et al (2002) KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood 100:3415–3418PubMedCrossRef

131.

Ferry JA, Sohani AR, Longtine JA, Schwartz RA, Harris NL (2009) HHV8-positive, EBV-positive Hodgkin lymphoma-like large B-cell lymphoma and HHV8-positive intravascular large B-cell lymphoma. Mod Pathol 22:618–626PubMedCrossRef

132.

Carbone A, Gloghini A, Santoro A (2012) In situ follicular lymphoma: pathologic characteristics and diagnostic features. Hematol Oncol 30:1–7. doi:10.1002/hon.993 PubMedCrossRef

133.

Ghia P (2011) Another piece of the puzzle: is there a “nodal” monoclonal B-cell lymphocytosis? Haematologica 96:1089–1091PubMedCrossRef

134.

Gibson SE, Swerdlow SH, Ferry JA, Surti U, Dal Cin P, Harris NL et al (2011) Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica 96:1144–1152PubMedCrossRef

Title: Early lesions in lymphoid neoplasia
Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology in Uppsala, Sweden
Authors: Falko Fend
José Cabecadas
Philippe Gaulard
Elaine S. Jaffe
Philip Kluin
Isinsu Kuzu
LoAnn Peterson
Andrew Wotherspoon
Christer Sundström
Publication date: 01-09-2012
Publisher: Springer-Verlag
Published in: Journal of Hematopathology / Issue 3/2012
Print ISSN: 1868-9256
Electronic ISSN: 1865-5785
DOI: https://doi.org/10.1007/s12308-012-0148-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Early lesions in lymphoid neoplasia

Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology in Uppsala, Sweden

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2012

Parvovirus B19 infection associated with severe chronic aplastic anaemia—a case report

Welcome to Lisbon!

ALK-positive anaplastic large cell lymphoma expressing membranous D2-40 immunopositivity and mimicking seminoma: potential diagnostic pitfall

Frequency of additional clonal populations detected by high sensitivity flow cytometry in patients with hairy cell leukemia

XVI meeting of the European Association for Haematopathology 2012 Abstracts

The word of the President!